Ping Zhang - May 27, 2025 Form 4 Insider Report for GYRE THERAPEUTICS, INC. (GYRE)

Role: Director
Signature: /s/ Ruoyu Chen, as attorney-in-fact for Ping Zhang
Stock symbol: GYRE
Transactions as of: May 27, 2025
Transactions value $: $0
Form type: 4
Date filed: 5/28/2025, 06:13 PM
Previous filing: Jan 7, 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Zhang Ping	Director	C/O GYRE THERAPEUTICS, INC., 12770 HIGH BLUFF DRIVE, SUITE 150, SAN DIEGO	/s/ Ruoyu Chen, as attorney-in-fact for Ping Zhang	2025-05-28	0002050176

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	GYRE	Stock Option (Right to Buy)	Award	$0	+250K		$0.00	250K	May 27, 2025	Common Stock	250K	$10.18	Direct	F1

Showing 1 to 1 of 1 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This option represents a right to purchase a total of 250,000 shares of the Issuer's common stock, 25% of which will vest on May 27, 2026, with the remaining vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer through each vesting date.